NCT01681277View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

BI 113608 PIB bid

powder for oral solution

DRUG

Placebo to BI 113608 PIB bid

powder for oral solution

DRUG

Placebo to BI 113608 PIB bid

powder for oral solution

DRUG

Placebo to BI 113608 PIB qd

powder for oral solution

DRUG

Placebo to BI 113608 PIB bid

powder for oral solution

DRUG

BI 113608 PIB bid

powder for oral solution

DRUG

BI 113608 PIB bid

powder for oral solution

DRUG

BI 113608 PIB qd

powder for oral solution

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY